Aptevo Therapeutics Inc.
Price Action
Technical Summary
DOWNTRENDAptevo Therapeutics Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 96), indicating clear outperformance against the broad market. Earnings growth of 100% provides fundamental context to the price action. Investors should exercise caution due to high volatility (96% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.78 | -4.73% | BELOW |
| 50 SMA | $4.86 | -6.38% | BELOW |
| 100 SMA | $5.21 | -12.70% | BELOW |
| 150 SMA | $8.41 | -45.88% | BELOW |
| 200 SMA | $13.16 | -65.42% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is APVO in an uptrend right now?
APVO has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is APVO overbought or oversold?
APVO's RSI (14) is 44. The stock is in neutral territory, neither overbought nor oversold.
Is APVO outperforming the market?
APVO has a Relative Strength (RS) Rating of 96 out of 99. Yes, APVO is a market leader, outperforming 96% of all stocks over the past 12 months.
Where is APVO in its 52-week range?
APVO is trading at $4.55, which is 43% of its 52-week high ($10.70) and 40% above its 52-week low ($0.50).
How volatile is APVO?
APVO has a Beta of 1.56 and 52-week volatility of 96%. It's more volatile than the S&P 500 - expect bigger swings.